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Abstract: The primary physiological function of mitochondria is to generate adenosine 
triphosphate  through  oxidative  phosphorylation  via  the  electron  transport  chain. 
Overproduction of reactive oxygen species (ROS) as byproducts generated from mitochondria 
have been implicated in acute brain injuries such as stroke from cerebral ischemia. It was 
well-documented  that  mitochondria-dependent  apoptotic  pathway  involves  pro-  and 
anti-apoptotic  protein  binding,  release  of  cytochrome  c,  leading  ultimately  to  neuronal 
death. On the other hand, mitochondria also play a role to counteract the detrimental effects 
elicited by excessive oxidative stress. Recent studies have revealed that oxidative stress 
and the redox state of ischemic neurons are also implicated in the signaling pathway that 
involves peroxisome proliferative activated receptor-γ (PPARγ) co-activator 1α (PGC1-α). 
PGC1-α is a master regulator of ROS scavenging enzymes including manganese superoxide 
dismutase  2  and  the  uncoupling  protein  2,  both  are  mitochondrial  proteins,  and  may 
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contribute to neuronal survival. PGC1-α is also involved in mitochondrial biogenesis that 
is  vital  for  cell  survival.  Experimental  evidence  supports  the  roles  of  mitochondrial 
dysfunction and oxidative stress as determinants of neuronal death as well as endogenous 
protective mechanisms after stroke. This review aims to summarize the current knowledge 
focusing  on  the  molecular  mechanisms  underlying  cerebral  ischemia  involving  ROS, 
mitochondrial dysfunction, apoptosis, mitochondrial proteins capable of ROS scavenging, 
and mitochondrial biogenesis.   
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1. Introduction 
Mitochondria  are  ubiquitous  intracellular  organelles  enclosed  by  a  double  membrane  structure.   
The primary function of mitochondria is the production of cellular energy in the form of adenosine 
triphosphate  (ATP)  by  the  mitochondrial  respiratory  chain  through  oxidative  phosphorylation. 
Mitochondrial oxidative phosphorylation consists of five multienzyme complexes (Complexes I–V) 
located in the mitochondrial inner membrane [1]. Biochemical evidence suggested that the majority of 
cerebral ATP consumption is used for operation of the electrogenic activity of neurons [2]. Adequate 
energy supply by mitochondria is therefore essential for neuronal excitability and survival. In addition 
to energy production, mitochondria also play a crucial role in the generation of reactive oxygen species 
(ROS)  and  regulation  of  apoptosis  [3,4],  both  have  been  implicated  as  important  factors  in  the 
pathogenesis of neurodegenerative diseases and cerebral ischemia [3,5]. 
Stroke is the leading cause of adult disability and the second or third leading cause of death in most 
of the developed countries. Data from the World Health Organization suggest that annually 15 million 
people worldwide suffer a stroke. Of these, 5 million die and another 5 million are left permanently 
disabled, placing an enormously heavy burden on family and society (The Atlas of Heart Disease and 
Stroke  2011  from  http://www.who.int/cardiovascular_diseases/resources/atlas/en/).  The  majority  of 
patients with stroke experience thrombotic or embolic events that result in ischemic brain injury. Thus, 
the  major  aim  of  stroke  research  is  to  develop  therapeutic  interventions  to  reduce  brain  damage 
through the understanding of pathogenic molecular mechanisms underlying ischemic insults.   
Recent evidence has suggested an intimate link between an excessive generation of ROS and the 
development of neuronal death in diverse neurological disorders. These include chronic neurodegenerative 
diseases such as amyotrophic lateral sclerosis and epilepsy as well as acute brain injury like brain 
trauma and cerebral ischemia [6,7]. It was also reported that oxidative stress from cerebral ischemia 
may  promote  amyloid  β  production  which  links  the  potential  connection  between  stroke  and 
Alzheimer's disease [8,9]. Excessive ROS generation can induce the functional and structural damage 
of neuronal cells and may play an important role in the pathophysiology of cerebral ischemia [10–12]. 
As  mitochondrial  dysfunction  with  excessive  oxidative  stress  may  play  a  crucial  role  in  ischemic Int. J. Mol. Sci. 2011, 12  7201 
 
cascades,  counteracting  this  detrimental  effect  through  better  understanding  the  neuronal  damage 
resulting from apoptotic or necrotic cell death should have the perspective in treating ROS-related 
disorders such as ischemic stroke.   
Emerging evidence showed that ROS-detoxifying system and mitochondrial biogenesis may play a 
pivotal  role  as  endogenous  protective  mechanisms  in  neurodegenerative  diseases  and  cerebral   
ischemia [12–15]. This review will focus on mitochondrial dysfunction in cerebral ischemia-associated 
neuronal  death  and  the  potential  role  of  peroxisome  proliferator-activated  receptor-γ  (PPARγ) 
co-activator 1α (PGC1-α) on ROS and mitochondrial biogenesis.   
2. Ischemic Cascade Involving Mitochondria and ROS 
The pathophysiological cascades following cerebral ischemia have been characterized in animal 
models of stroke [16–18]. The ischemic event begins with reduced blood flow to the areas supplied by 
the occluded arteries. The lack of oxygen, glucose, and other nutrients leads to a state of disturbed 
cellular homeostasis, culminating in cell death. The cellular events leading to ischemic neuronal death 
have been extensively studied and the probable sequence of events involved in ischemic neuronal 
death is depicted in Figure 1. In this section, we focus on the detrimental effects of oxidative and 
nitrosative stress generated from mitochondria over neuronal injury under cerebral ischemia.   
Figure  1.  Schematic  overview  of  selected  cellular  events  in  the  ischemic  brain.  The 
ischemic  event  begins  with  reduced  blood  flow  to  the  area  supplied  by  the  occluded 
arteries. The lack of oxygen, glucose, and other nutrients leads to an ischemic cascade 
culminating in cell death. EAA = excitatory amino acid; ATP = adenosine triphosphate; 
CBF = cerebral blood flow; nNOS = neuronal nitric oxide synthase; NO = nitric oxide;   
↑ and ↓ denote increase and decrease, respectively. 
CBF
Nutrients
ATP
EAA uptake Ion dyshomeostasis
Ca++
Kinases, protease,
lipase, nNOS
Membrane 
degradation
Bcl 2 gene family
Inflammatory
mediator
Mitochondral
dysfunction
Free radical,
NO
Caspases
activation
DNA
damage
Cell death
Brain ischemia
 Int. J. Mol. Sci. 2011, 12  7202 
 
2.1. Mitochondria and Oxidative Stress in Cerebral Ischemia 
Oxidative  stress  is  defined  as  an  imbalance  between  the  production  of  ROS  and  the  ability  to 
readily  detoxify  the  reactive  intermediates  in  a  biological  system.  The  effects  of  oxidative  stress 
depend upon the severity of these changes. A small perturbation may be overcome by the endogenous 
anti-oxidant system. However, severe oxidative stress can cause cell death either via an apoptotic or a 
necrotic pathway [19]. In living cells including neurons, ROS can be generated under stimuli such as 
hypoxia,  serum  deprivation  or  cytokine  stimulation  by  several  sources  mainly  including  NADPH 
oxidase, 5-lipoxygenase and mitochondria [20]. Among them, mitochondria are the major organelles 
that produce ROS within cells [3,21,22]. Under successive oxidative stress the free electrons on the 
mitochondrial  electron  transport  chain  may  leak  out  and  react  with  molecular  oxygen,  thereby 
generating superoxide anion as metabolic byproducts during respiration. Nitric oxide (NO) may react 
with superoxide anion to produces the highly reactive peroxynitrite anion (ONOO
-) that reacts with 
DNA, proteins, and lipids. Together, modification of these macromolecules by ROS and/or reactive 
nitrosative species (RNS) plays an important role in many physiological and pathological conditions, 
notably ischemia-reperfusion injury, neurodegenerative diseases, aging, and cancer [12,23–25]. Thus, 
it is crucial to maintain low levels of ROS for normal cell functions, whereas prolonged increases in 
mitochondrial activity may carry an inherent risk of increasing ROS levels. After cerebral ischemia, 
the balance between ROS production and clearance are compromised, which may result in oxidative 
stress-induced signaling and cell injury. The pathogenic role of oxygen free radicals in ischemic brain 
injury has been reviewed elsewhere [3].   
2.2. Mitochondria and Nitrosative Stress in Cerebral Ischemia 
Brain ischemia also triggers the activation of various isoforms of nitric oxide synthases (NOSs). 
These include the constitutively expressed neuronal (nNOS) and endothelial (eNOS) and the inducible 
(iNOS) isoforms. The role of NO in ischemic brain injury is complex. Excessive NO formation may be 
cytotoxic  by  directly  inhibiting  enzymes  that  catalyze  vital  cellular  functions  involved  in  energy 
metabolism and DNA synthesis. The deleterious effects of NO might be attributed to its well-known 
affinity for iron and thiol groups [26,27]. NO may also contribute to free radical generation by forming 
peroxynitrite anions, which then forms the cytotoxic hydroxyl radical and superoxide anion [28].   
It  has  been  shown  that  mitochondria  contain  their  own  isoform  of  NOS,  mitochondrial  NOS 
(mtNOS), at the inner membrane [29,30]. The existence of mtNOS is still under debate because of the 
concerns for contamination during mitochondrial preparations and the lack of antibody specificity for 
mtNOS as these antibodies also cross-react with other NOS isoform, including eNOS and nNOS [31]. 
Nevertheless, more recent data support mtNOS as an independent form of NOS and mtNOS activities 
were reported in multiple organs from from mouse and rat, including brain, heart, kidney, thymus, and 
skeletal muscle  [32].  mtNOS is thought to be synthesized in the cytosol and  then  translocated into 
mitochondria [33] but the mechanism of this  translocation remains unknown  at  present. As  mtNOS 
continuously controls mitochondrial respiration [29,30], it is considered a key enzyme of reperfusion 
injury [34] and may be related to apoptosis after stroke. To date, only a limited number of studies has Int. J. Mol. Sci. 2011, 12  7203 
 
reported correlation between mtNOS and ischemia [35]. Uncovering the roles of mtNOS after cerebral 
ischemia may thus provide novel therapeutic strategies for stroke patients. 
Recent studies [36] also suggested that nitrosative stress due to generation of excessive NO could 
mediate  excitotoxicity  in  part  by  triggering  protein  misfolding,  aggregation,  and  mitochondrial 
fragmentation. S-Nitrosylation, the covalent reaction of NO with specific protein thiol groups, represents 
a  convergent  signal  pathway  contributing  to  NO-induced  protein  misfolding  and  aggregation  that 
compromised dynamics of mitochondrial fission-fusion process, thus leading to neurotoxicity [36]. Role 
of  nitrosative  stress  and  mitochondrial  dysfunction  in  cerebral  ischemia  is  less  well  explored  and 
warrants further studies. 
3. Pro- and Anti-Apoptotic Proteins Associated with Mitochondria-Dependent Apoptosis in 
Cerebral Ischemia 
Mitochondria and neuronal death in ischemia-induced cell death is no exception to the emerging 
complexities of the molecular control of other neurological disorders such as neurodegeneration or 
seizure  [13,37].  Cell  death  in  the  ischemic  brain  reflects  a  transition  between  activated  pro-death 
factors and cellular pro-survival responses over hours or even days. Neurons in the final stages of their 
demise  often  present  a  mixed  picture  with  cell  death  in  a  programmed/controlled  (apoptotic)  or 
uncontrolled/passive (necrotic) manner. 
Programmed cell death mechanisms associated with cellular apoptosis have been shown in human 
and animal studies that support apoptotic cell death playing an important role in ischemia-induced 
brain  damages  [38–41].  Factors  such  as  variation  in  duration  and  severity  of  ischemia,  metabolic 
disturbance, bioenergetics failure during or after ischemia and age- or genetic-specific factors may all 
contribute to determining the eventual pathway of cell death [42,43]. A critical determinant of the 
eventual cell death fate resides in intracellular ATP concentration, the production of which depends on 
the structural and functional integrity of the mitochondria. Whereas ATP depletion is associated with 
necrosis, ATP is required for the progression of apoptosis [44]. 
In ischemic stroke, a necrotic core is surrounded by a zone known as the “ischemic penumbra” that 
is  less  affected  and  functionally  silent  tissue.  Penumbral  area,  resulted  from  partial  reduction  of 
cerebral blood flow, remains metabolically active and represents the region where opportunities exist 
for salvage of neurons via post-stroke therapy [45]. Recent research has revealed that many neurons in 
the ischemic penumbra or peri-infarct zone may undergo apoptosis after several hours or days [46–48] 
that can potentially be rescued after stroke. Intervention of this apoptotic process in the penumbra 
would seem to be an achievable therapeutic target for limiting cerebral infarct volume after clinical 
stroke. To update our knowledge about apoptosis in this ischemic paradigm would provide a basis for 
the novel anti-apoptotic intervention. 
Given its role as the cellular powerhouse, the mitochondrion is emerging as a key participant in cell 
death because of its association with an ever-growing list of apoptosis-related proteins [49,50]. The evidence 
of Bcl-2 family involved in ischemia-induced neuronal cell death has also been demonstrated [51–55]. 
The Bcl-2 protein family is a principal regulator of mitochondrial membrane integrity and function. Int. J. Mol. Sci. 2011, 12  7204 
 
According to the structural homology they are classified as the anti-apoptotic proteins including Bcl-2, 
Bcl-xL, and Bcl-w, the pro-apoptotic proteins including Bax and Bak, as well as the BH3-only proteins 
including Bad, Bid, Bim, Noxa, and p53-upregulated modulator of apoptosis (PUMA) [3].   
A  variety  of  key  events  in  apoptosis  focus  on  mitochondria,  including  the  release  of  several 
apoptogenic  factors  (such  as  cytochrome  c,  apoptosis-inducing  factor  or  AIF,  endonuclease  G, 
Smac/DIABLO, and HtrA2/OMI), changes in electron transport, loss of mitochondrial transmembrane 
potential,  altered  cellular  redox  states,  and  participation  of  pro-  and  anti-apoptotic  Bcl-2  family 
proteins [49,56]. Studies have shown that after cerebral ischemia, BH3-only proteins were upregulated, 
denoting that this ischemic process triggers various apoptotic pathways [57–60]. One of the decisive 
steps of the apoptotic cascade is related to the mitochondrial permeability transition pores (mPTPs) [61]. 
Transient opening of mPTPs in the mitochondrial inner membrane under conditions of cellular stress 
causes the mitochondrial transmembrane potential to collapse and elicits the release of cytochrome c as 
well as other pro-apoptotic molecules that together initiate the apoptotic cascade. Cytochrome c interacts 
with apoptosis activating factor-1 (Apaf-1), deoxyadenosine triphosphate (dATP), and procaspase-9 to 
form  the  apoptosome,  which  activates  procaspase-9  and  following  with  caspase-9 to cleave  and 
activate caspase-3 [62–64].  Smac  released  from  mitochondria  binds  to,  and  hence  neutralizes,  the 
anti-apoptotic effects of the X chromosome-linked inhibitor-of-apoptosis protein (XIAP), which can 
prevent procaspase activation and inhibits activities of activated caspases after cerebral ischemia [65,66]. 
AIF  also  translocates  from  mitochondria  to  the  nucleus  and  induces  apoptosis  after  focal  cerebral 
ischemia and inhibition of poly(ADP-ribose) polymerase and Bid reduces nuclear AIF translocation [67]. 
4. PGC-1α–an Endogenous Protective Mechanism Involving ROS and Mitochondria Biogenesis 
in Cerebral Ischemia 
Under  cerebral  ischemia,  a  detrimental  pathway  begins  with  decreased  CBF,  increased  ROS, 
triggering apoptotic pathway, and finally leads to neuronal death [10,16]. On the other hand, there are 
molecules that can prevent caspase activation in the cytosol. Inhibitor of apoptosis protein (IAP) family 
is known to suppress apoptosis by preventing activation of procaspases and inhibiting enzymatic activity 
of active caspases [68] or interacting with Smac [69]. The PI3-K/Akt survival signaling pathway is 
upregulated by superoxide dismutase 1 overexpression and suppress ischemic neuronal death during 
stroke [70]. 
Previous studies have shown that the PGC-1α is a potent stimulators of mitochondrial respiration 
and gene transcription in liver, heart, and skeletal muscle [71]. Several neurodegenerative diseases 
such as Parkinson’s disease, Alzheimer’s disease, and Huntington’s disease have been associated with 
impaired  mitochondrial  function  and  decreased  expression  of  genes  involved  in  mitochondrial 
oxidative phosphorylation [72]. It was reported that PGC-1α knockout mice have a striking spongiform 
lesion in the striatum, the brain region primarily affected in Huntington’s disease patients or lesions 
observed in substantia nigra and hippocampus, two regions severely affected in patients suffering from 
Parkinson’s  disease  and  Alzheimer’s  disease,  respectively  [73].  Activation  or  overexpression  of  the 
PGC-1α could be used to compensate for neuronal mitochondrial loss and suggest that therapeutic Int. J. Mol. Sci. 2011, 12  7205 
 
agents  activating  PGC-1α  would  be  valuable  for  treating  neurodegenerative  diseases  in  which 
mitochondrial  dysfunction  and  oxidative  damage  play  an  important  pathogenic  role  [74].  Recent 
studies have revealed that oxidative stress and the redox state of ischemic neurons are also implicated 
in  the  signaling  pathway  that  involves  PGC1-α.  Two  mitochondrial  proteins-uncoupling  protein  2 
(UCP2) and superoxide dismutase 2 (SOD2) that are both regulated by PGC1-α play a pivotal role to 
counteract the damaging effect elicited by excessive oxidative stress [13]. In this section, we review 
the importance of PGC-1α-mediated ROS metabolism and mitochondrial biogenesis in relation to 
cerebral ischemia. 
4.1. PGC-1α in Mitochondria-Related ROS Metabolism under Cerebral Ischemia 
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that 
may regulate lipid and lipoprotein metabolism, glucose homeostasis, cell proliferation and differentiation, 
as well as apoptosis. 
Importantly,  PPARs  also  modulate  the  inflammatory  and  oxidative  responses  [75].  Evidence 
revealed that PPARs have beneficial effects in inflammatory diseases through regulation of cytokine 
production  and  adhesion  molecule  expression  by  interfering  with  the  transactivation  capacity  for 
nuclear  factor-κB  (NF-κB),  activator  protein-1  (AP-1),  and  signal  transducers  and  activators  of 
transcription  (STAT)  [75–77].  It  is  well  documented  that  activation  of  PPARγ  can  attenuate 
post-ischemic inflammation and damage [21,78,79]. In recent studies, PPAR delta also revealed its 
pivotal role in ischemic injury and warrants further investigation for the development of therapeutic 
strategy for stroke [80,81]. Since the identification of PPARγ as a PGC-1α transcription factor target, a 
variety  of  additional  PGC-1  target  nuclear  receptors  have  been  identified  which  include  PPARα, 
PPARβ/delta, thyroid hormone receptor, retinoid receptors, glucocorticoid receptor, estrogen receptor, 
liver X receptor , and the estrogen-related receptors [82]. PGC-1α is a transcriptional coactivator that 
transduces  many  physiological  stimuli  into  specific  metabolic  programs  such  as  gluconeogenesis, 
thermogenesis, fatty acid oxidation and mitochondrial biogenesis [82–84]. Consistent with its emerging 
role as a central regulator of energy metabolism, PGC-1α is abundantly expressed in tissues with high 
metabolic rates such as in striated muscle, brown adipose tissue, liver, and brains [13,82]. 
PGC-1α is activated under oxidative stress. It has been reported that, in cultured skeletal myotubes 
with ischemia-like conditions, PGC-1α gene expression is induced [85]. PGC-1α is also expressed in 
the mouse cerebral subcortex under hypobaric hypoxia [86] and in skeletal muscle with hibernation,   
a  known  hypoxic  state  [87].  These  studies  denote  the  pivotal  roles  of  PGC-1α  in  tissues  under 
ischemia-hypoxia  condition.  In  neuronal  cells,  it  was  reported  that  PGC-1α  is  required  for  the 
induction of many ROS-detoxifying proteins, including glutathione peroxidase, catalase, UCP2 and 
SOD2  [13].  Down-regulation  of  PGC-1α  expression  in  mice  exacerbates  the  detrimental  effects   
of  1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine  (MPTP)  to  substantia  nigra  or  kainic  acid  to 
hippocampus [13]. In contrast, an increased PGC-1α expression may protect cultured neural cells from 
oxidative stress-mediated cell death [13]. Nevertheless, the exact roles of PGC-1α in ROS metabolism 
under  cerebral  ischemia  remain  largely  unexplored.  In  view  of  the  crucial  relationship  between Int. J. Mol. Sci. 2011, 12  7206 
 
ischemia-induced  neuronal  damage  and  overproduction  of  ROS,  it  is  reasonable  to  speculate  the 
importance of PGC-1α in this paradigm.   
Two important ROS-detoxifying proteins have been identified in mitochondria, namely UCP2 and 
SOD2 [88,89]. They play a crucial role in the fate of neurons and damage progression after ischemic 
stroke  by  regulation  of  ROS  production  [90,91].  Upregulation  of  UCP2  after  cerebral  ischemia 
decreased  the  release  of  ROS  and  reduced  neuronal  loss  in  the  brain  tissue  that  offers  a  novel 
neuroprotection against ischemic brain injury [21,91,92]. Furthermore, animals overexpressing SOD2 
showed  a  protective  effect  against  oxidative  stress-induced  neuronal  damage  after  transient  focal 
cerebral  ischemia  [93,94].  Importantly,  UCP2  and  SOD2  have  been  proposed  to  be  direct  targets 
downstream of PGC-1α [13,95]. We have demonstrated recently that under transient ischemic condition, 
ROS overproduction may stimulate the activation of PGC-1α signaling pathway, further triggering 
upregulation  of  UCP2  and  SOD2  in  hippocampal  CA1  neurons  [12].  Knock-down  of  PGC-1α 
expression  by  pretreatment  with  PGC-1α  antisense  oligodeoxynucleotide  (ODN)  diminished  the 
expression of UCP2 and SOD2 that led to exacerbation of oxidative damage and augmentation of 
delayed  neuronal  death  in  the  hippocampus  after  transient  global  ischemia.  Therefore,  PGC-1α 
signaling pathway may emerge as a new potential target for future development of more effective 
neuroprotective strategies against ischemic brain injury. 
4.2. PGC-1α Signaling Pathway and Mitochondrial Biogenesis under Cerebral Ischemia 
Mitochondria are important for cellular homeostasis. Recent studies have shown that mitochondrially 
formed oxidants are mediators of molecular signaling and have been implicated in mitochondria-dependent 
apoptosis.  However, oxidative stress and the redox state are also involved in the survival signaling 
pathway  of  the  stressed  cells.  Nevertheless,  mitochondria  are  not  static  organelles.  Fluctuating 
homeostatic demands and inherent production of ROS cause progressive damage of mitochondria and 
require dynamic regulation of their turnover, cellular contents, biological functions, as well as total 
numbers of this vital intracellular organelle [96]. This is in particular crucial for proper function of 
post-mitotic neurons; however, the information is limited regarding the role of mitochondrial biogenesis 
in neural  cells. Mitochondrial abundance as well as the copy number and integrity of mtDNA  in 
mammalian  cells may alter under pathological conditions with increased oxidative stress and during 
aging process [97,98]. Within a certain level, ROS may activate stress responses by altering expression 
of  specific  nuclear  genes  to  maintain  the  normal  energy  metabolism  and  cope  with  hazardous 
environments for cell survival. Once beyond a certain threshold, ROS may cause oxidative damage to 
mtDNA and other biomolecules of the affected cells to elicit apoptosis. It has been demonstrated that a 
number of protein factors encoded by nuclear genes are involved in the biogenesis of mitochondria and 
respiratory functions [98]. Nuclear respiratory factors 1 and 2 (NRF-1 and NRF-2) are transcriptional 
regulators that act on the nuclear genes coding for constituent subunits of the oxidative phosphorylation 
system.  In  addition,  they  also  regulate  the  expression  of  many  other  genes  involved  in  mtDNA 
replication via binding to the consensus sequences in the promoters of the oxidative phosphorylation 
genes in the nucleus [97–99]. Mitochondrial transcription factor A (Tfam) is a transcription factor that Int. J. Mol. Sci. 2011, 12  7207 
 
acts on the promoters within the D-loop region of mtDNA and regulates the replication and transcription 
of the mitochondrial genome [98]. It has been established that the Tfam gene contains consensus-binding 
sites for both NRF-1 and NRF-2, which provide a unique  mechanism for the cells to integrate the 
expression of nuclear DNA-encoded proteins with the transcription of genes encoded by mtDNA [97,98]. 
It has been shown that PGC-1α may be a major regulator of mitochondrial biogenesis [84]. A recent 
study demonstrates that hypoxia-ischemia induces mitochondrial biogenesis. After hypoxia, increases in 
mitochondrial DNA, total mitochondrial number, expression of the mitochondrial transcription factors 
downstream of PGC-1α (NRF1 and Tfam), and the mitochondrial protein HSP60 are detected [15]. In 
view of mitochondria as an energy center and important for cellular homeostasis, exploring the roles of 
mitochondrial biogenesis as an endogenous protective response to cope with ischemic insult may help us 
to develop a strategy to enhance this beneficial effect and counteract the ischemia-related detrimental 
effects. In our recent study, we showed that, under transient global ischemia, the PGC-1α signaling 
pathway is activated, which may trigger the UCP2 and SOD2 expression and promote mitochondrial 
biogenesis in the hippocampal CA1 subfield. In keeping with the role of mitochondrial biogenesis as a 
potential  endogenous  protective  mechanism  [15,100],  boosting  the  signal  transduction  pathways 
upstream of mitochondrial biogenesis, such as the PGC-1α signaling cascade, may therefore become a 
novel  target  for  a  therapeutic  strategy  against  ischemic  brain  damage  [14].  The  probable  roles  of 
PGC-1α with mitochondria proteins-UCP2 and SOD2-as well as mitochondrial biogenesis in ischemic 
condition is depicted in Figure 2. 
Figure  2.  Proposed  role  of  PGC-1α in  ischemic  condition. ROS  overproduction may 
stimulate the activation of PGC-1α signaling pathway, further triggering upregulation of 
mitochondrial  proteins,  including  UCP2 and SOD2, in ischemic neurons. PGC-1α also 
regulates NRF-1, NRF-2 and Tfam expression as well as mitochondrial biogenesis that may 
have protective effects in ischemic condition. PGC-1α = peroxisome proliferative activated 
receptor-γ co-activator 1α; UCP2 = uncoupling protein 2; SOD2 = superoxide dismutase 2; 
NRFs  =  Nuclear  respiratory  factors;  Tfam  =  Mitochondrial  transcription  factor  A;   
↑ and ↓ denote increase and decrease, respectively. 
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5. Conclusions 
Numerous  studies  report  the  involvement  of  ROS  in  cell  death  after  cerebral  ischemia.  ROS 
contribute  not  only  to  injury  of  macromolecules  such  as  lipids,  proteins,  and  DNA,  but  also  to 
transduction  of  apoptotic  signals.  Mitochondrial  dysfunctions  occur  as  a  consequence  of  cerebral 
ischemia  and  promote  ischemia-induced  neuronal  cell  death,  especially  the  intrinsic  pathway  of 
apoptotic cell death. Conversely, endogenous protective pathways exist to counteract these detrimental 
effects induced by ischemia including mitochondria proteins UCP2 and SOD2, which are all regulated 
by  PGC-1α.  Therefore,  mitochondria  can  be  considered  as  a  target  for  potential  neuroprotective 
strategies in cerebral ischemia. Future studies of these cell death/survival mechanisms subsequent to 
ischemic attack may provide unique information regarding molecular targets for therapeutic strategies 
in clinical stroke. Protection of the mitochondria from bioenergetics failure and oxidative/nitrosative 
stress resulting in apoptosis in the ischemic tissue may open a new vista to the development of more 
effective neuroprotective strategies against ischemia-induced brain damage.   
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